This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

Induction Therapy for Patients With FLT3 Mutated Acute Myeloid Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04982354
Recruitment Status : Recruiting
First Posted : July 29, 2021
Last Update Posted : May 3, 2023
Jazz Pharmaceuticals
Information provided by (Responsible Party):
Baptist Health South Florida

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 1, 2031
Estimated Study Completion Date : August 1, 2032